SCHEMBL8957386

SCHEMBL8957386

O=C(NCCO[N+](=O)[O-])c1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.70
KMT2A Q03164 3/20 0.70
CYP2C9 P11712 2/20 0.70
CYP2C19 P33261 2/20 0.70
ALOX15 P16050 1/20 0.70
HSD17B10 Q99714 1/20 0.70
SMN1; SMN2 Q16637 5/20 0.63
HPGD P15428 4/20 0.60
NPC1 O15118 4/20 0.59
RAB9A P51151 4/20 0.59
ALDH1A1 P00352 3/20 0.56
RECQL P46063 1/20 0.55
NPSR1 Q6W5P4 1/20 0.54
LMNA P02545 3/20 0.53
HTT P42858 2/20 0.53
MAPT P10636 1/20 0.53
PRSS1 P07477 1/20 0.53
CTSG P08311 1/20 0.53
CTRB1 P17538 1/20 0.53
CMA1 P23946 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9475142 0.84 KMT2A (0.59) MEN1KMT2ACYP2C9CYP2C19ALOX15
SCHEMBL3642315 0.83 GAA (0.53) MEN1KMT2ACYP2C9CYP2C19ALOX15
Nicorandil SCHEMBL29512234 0.83 KMT2A (1.00) MEN1KMT2ACYP2C9CYP2C19ALOX15
Nicorandil SCHEMBL34547 0.83 KMT2A (1.00) MEN1KMT2ACYP2C9CYP2C19ALOX15
Nicorandil SCHEMBL5051667 0.83 KMT2A (1.00) MEN1KMT2ACYP2C9CYP2C19ALOX15
Nicorandil SCHEMBL9559453 0.82 KMT2A (0.93) MEN1KMT2ACYP2C9CYP2C19ALOX15
SCHEMBL9152126 0.82 KMT2A (0.56) MEN1KMT2ACYP2C9CYP2C19ALOX15
Nicorandil SCHEMBL10766084 0.82 KMT2A (0.97) MEN1KMT2ACYP2C9CYP2C19ALOX15
SCHEMBL9084228 0.81 MEN1 (0.57) MEN1KMT2ACYP2C9CYP2C19ALOX15
SCHEMBL4432503 0.80 KMT2A (0.59) MEN1KMT2ACYP2C9CYP2C19ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0689435-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1996-01-03 EP claimed
WO-1994021248-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1994-09-29 WO claimed
EP-0689435-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1996-01-03 EP disclosed
WO-1994021248-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1994-09-29 WO disclosed
EP-0540544-A1 BENZOIC ACID SUBSTITUTED DERIVATIVES HAVING CARDIOVASCULAR ACTIVITY. ITALFARMACO SPA (IT) 1993-05-12 EP disclosed